Primary Biliary Cirrhosis

被引：1175

作者：

Lindor, Keith D. ^{[1
]}

Gershwin, M. Eric ^{[2
]}

Poupon, Raoul ^{[3
]}

Kaplan, Marshall ^{[4
]}

Bergasa, Nora V. ^{[5
]}

Heathcote, E. Jenny ^{[6
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA

[2] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA

[3] Hosp St Antoine, Paris, France

[4] Tufts Med Ctr, Div Gastroenterol, Boston, MA USA

[5] Metropolitan Hosp Ctr, Dept Med, New York, NY 10029 USA

[6] Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada

来源：

HEPATOLOGY | 2009年 / 50卷 / 01期

关键词：

PLACEBO-CONTROLLED TRIAL; URSODEOXYCHOLIC-ACID THERAPY; RANDOMIZED-CONTROLLED-TRIALS; NODULAR REGENERATIVE HYPERPLASIA; PRIMARY SCLEROSING CHOLANGITIS; EXCESSIVE DAYTIME SOMNOLENCE; HEPATITIS OVERLAP SYNDROME; ORAL NALMEFENE THERAPY; BLIND CONTROLLED-TRIAL; CHRONIC LIVER-DISEASE;

D O I：

10.1002/hep.22906

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：291 / 308

页数：18

共 221 条

[1] ABBOUD TK, 1990, ANESTH ANALG, V71, P367
[2] Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy
Abraham, Susan C.
Kamath, Patrick S.
Eghtesad, Bijan
Demetris, Anthony J.
Krasinskas, Alyssa M.
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (11) : 1454 - 1461
[3] Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites
Ala, A
Stanca, CM
Bu-Ghanim, M
Ahmado, I
Branch, AD
Schiano, TD
Odin, JA
Bach, N
[J]. HEPATOLOGY, 2006, 43 (03) : 525 - 531
[4] Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis
Allocca, M.
Crosignani, A.
Gritti, A.
Ghilardi, G.
Gobatti, D.
Caruso, D.
Zuin, M.
Podda, M.
Battezzati, P. M.
[J]. GUT, 2006, 55 (12) : 1795 - 1800
[5] International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis
Alvarez, E
Berg, PA
Bianchi, FB
Bianchi, L
Burroughs, AK
Cancado, EL
Chapman, RW
Cooksley, WGE
Czaja, AJ
Desmet, VJ
Donaldson, RT
Eddleston, ALWF
Fainboim, L
Heathcote, J
Homberg, JC
Hoofnagle, JH
Kakumu, S
Krawitt, EL
Mackay, IR
MacSween, RNM
Maddrey, WC
Manns, MP
McFarlane, IG
zum Büschenfelde, KHM
Mieli-Vergani, G
Nakanuma, Y
Nishioka, M
Penner, E
Porta, G
Portmann, BC
Reed, WD
Rodes, J
Schalm, SW
Scheuer, PJ
Schrumpf, E
Seki, T
Toda, G
Tsuji, T
Tygstrup, N
Vergani, D
Zeniya, M
[J]. JOURNAL OF HEPATOLOGY, 1999, 31 (05) : 929 - 938
[6] *AM HEART ASS, METH MAN
[7] Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
Angulo, P
Batts, KP
Therneau, TM
Jorgensen, RA
Dickson, ER
Lindor, KD
[J]. HEPATOLOGY, 1999, 29 (03) : 644 - 647
[8] Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial
Angulo, P
Dickson, ER
Therneau, TM
Jorgensen, RA
Smith, C
DeSotel, CK
Lange, SM
Anderson, ML
Mahoney, DW
Lindor, KD
[J]. JOURNAL OF HEPATOLOGY, 1999, 30 (05) : 830 - 835
[9] Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
Angulo, P
Jorgensen, RA
Keach, JC
Dickson, ER
Smith, C
Lindor, KD
[J]. HEPATOLOGY, 2000, 31 (02) : 318 - 323
[10] Angulo P, 2001, AM J GASTROENTEROL, V96, P3152

← 1 2 3 4 5 6 7 8 9 10 →